SlideShare a Scribd company logo
At least 2 out of 3
If only 1 finding
• Disturbance of the structural or functional integrity of the optic nerve, in which;
IOP > 21 mmHg
Glaucomatous ONH damage
Characteristic visual field changes
Open AC angle
Absent signs of 2ry glaucoma or a non glaucomatous cause of optic
neuropathy
• The higher the IOP, the greater the likelihood of glaucoma
• More common in old age
• More common in Black individuals
• Siblings, offspring
• More common in Myopic individuals
• Hypertension, Diabetes, Migraine
• Direct mechanical damage to RNF
• Ischaemic damage
• Nothing
• Except in late cases when the patient complains of restricted visual field
• Steroids (elevates
IOP), ℬ blockers e.g.
for hypertension
(lowers IOP)
• Trauma, surgery, inflammation
• Cardiovascular,
respiratory disease; for
proper tailoring of
medications
• Phasing (Note time of the day), Asymmetry
• C/D ratio (Asymmetry), Peri papillary
area, RNFL defect
• Not affected except in advanced cases
• Not affected except in advanced cases (RAPD in post glaucomatous
OA)
• Open angle
• To exclude causes of 2ry glaucoma
• Measure IOP while the patient is fasting
• Drink 1 litre over 5 - 15 minutes
• Measure IOP subsequently every 15
minutes for one hour
• A rise in IOP of 6 to 8 mmHg or an increase
from baseline of 30% or more at any time
during the hour was considered a positive
test.
• To adjust the IOP reading according to the central corneal thickness.
• Pseudo-colour map of ONH & peri-papillary RNFL thickness.
• The visual field defect
corresponds to the pattern
of fibres in the retinal area
served
‫مهم‬‫جدا‬
• can form at a relatively early stage, often superonasally
from the earliest to the latest
•the defect is bounded by the horizontal midline, corresponding to the retinal nerve
fibre layer horizontal raphe.
•Less common than nasal step, WHY?!!
•Develop from coalescent para-central scotomas
•Baring of the blind spot = extension from the blind spot around fixation
• Develops when superior and inferior arcuate defects become continuous
• A small island of central vision
• 1ry vs 2ry glaucoma
• Causes of visual field defects mimic glaucoma field defects e.g. ONH drusen, tilted
ONH
• Prevent functional impairment of vision within the patient’s lifetime by
slowing the rate of ganglion cell loss closer to that of the normal
population.
• Increases uveoscleral outflow
• Increases trabecular outflow
• Latanoprost
• Once daily at bed time
• Conjunctival hyperaemia
• Eye lash thickening, lengthening & hyper pigmentation
• Irreversible iris hyper pigmentation
• Peri ocular skin hyper pigmentation
• Cystoid macular edema
• Promotion of herpetic keratitis
• Anterior uveitis
• Travaprost • Bimatoprost
• Decreases aqueous production by ciliary epithelium
• Timolol
• Twice daily (not at bed time to avoid profound hypotension)
• Ocular: Allergy, PEE
• Systemic:
1. Bronchospasm; contraindicated in asthmatic patients
2. Bradycardia, Hypotension, Heart block, Heart failure
3. Dyslipidemia, headache, decrease lipido
• Betaxolol (increases ON blood flow) • Levobunolol
• Decreases aqueous production by ciliary epithelium
• Increases uveoscleral outflow
• Brimonidine
• Twice daily
• Ocular: Allergic conjunctivitis
• Systemic:
1. Xerostomia
2. Cross the blood brain barrier (CI under the
age of 2 years)
• Apraclonidine
• Decreases aqueous production by ciliary epithelium
• Dorzolamide
• Twice daily
• Ocular: Allergic blepharo-conjunctivitis
• Systemic:
1. Idiosyncrasy (Bone marrow suppression)
• Brinzolamide
•improve convenience and patient compliance
•more cost effective
• Timolol + Dorzolamide (Cosopt)
• Timolol + Travaprost (Duotrav)
• Timolol + Brimonidine (Combigan)
• Decreases aqueous production by ciliary epithelium
• Acetazolmide
• Used for control of acute attack of glaucoma with high IOP
• Ocular: Choroidal effusion
• Systemic:
1. Paraesthesia
2. Renal stones
3. GIT disturbances
4. Malaise
•Create an osmotic gradient so that water is ‘drawn out’ from the
vitreous into the blood
• Mannitol (IV)
• Used for control of acute attack of glaucoma with high IOP
• Systemic:
1. Cardiovascular overload
2. Urine retention
3. Headache
• Glycerol (Oral) • Isosorbide (Oral)
• Beta blockers
• CAI
• Alpha 2 agonists
• PG derivatives
• Alpha 2 agonists
• Start with single line (usually PG derivative or Beta blocker)
• Choose the drug with fewest side effects, lowest concentration
• Usually after 2-4 weeks
• Response to the drug is assessed against the desired target IOP
• Target IOP is tailored according to the patient:
Age
Presenting IOP
ONH changes
Field defects
• Subsequent assessment is set for further 3-6 months
• ONH exam is done in each visit
• Perimetry is done every 6-12 months
• Gonioscopy is done every 12 months as AC angle tend to narrow with age
• Patient compliance • Proper target
IOP setting
• Diurnal
variation
• Substitute to another drug, then review
• Add another drug or use fixed combination
Laser trabeculoplasty (LTP) involves the delivery of
laser to the trabecular meshwork with the aim of
enhancing aqueous outflow and thereby lowering
IOP.
ALT SLT
LASER Argon Nd YAG
Mechanism of
action
Thermal damage to TM, leading to
mechanical opening of TM spaces
Selectively target melanin pigment in
trabecular meshwork (TM) cells, leaving
non-pigmented structures unscathed.
Repeatability Not repeatable Could be repeated
Electron
Microscopy of TM
• Poorly controlled POAG with medical or laser therapy
• Poor compliance with medical treatment
• Advanced POAG requiring very low target IOP
• To create a fistula between the AC & the
sub-conjunctival space from which the
aqueous drains.
• Blebitis, Endophthalmitis
• Treatment; IV Fortified
antibiotics (Vancomycin +
Ceftazidime), Vitrectomy
• With Deep AC >> Filed bleb (Sub-conjunctival fibrosis)
• With Shallow AC >> Pupillary Block
>> Malignant Glaucoma (Aqueous misdirection)
• With Deep AC >> Choroidal detachment
• With Shallow AC >> Over Filtration
>> Bleb Leak
•In non-penetrating filtration
surgery the AC is not entered
and the internal trabecular
meshwork is preserved, thus
reducing the incidence of
postoperative over filtration with
hypotony & its potential sequelae.
•Two concentric lamellar scleral
flaps are fashioned & the deep
flap excised leaving behind a thin
membrane consisting of
trabeculum/Descemet membrane
through which aqueous diffuses
from the AC to the subconjunctival
space.
Primary open angle glaucoma

More Related Content

What's hot

Ischemic optic neuropathies
Ischemic optic neuropathiesIschemic optic neuropathies
Ischemic optic neuropathies
Hasika Ravula
 
Anatomy of vitreous
Anatomy of vitreousAnatomy of vitreous
Anatomy of vitreous
rakesh jaiswal
 
Congenital third ( oculomotor )nerve palsy
Congenital third ( oculomotor )nerve palsyCongenital third ( oculomotor )nerve palsy
Congenital third ( oculomotor )nerve palsy
Vinitkumar MJ
 
Vitreous hemorrhage
Vitreous hemorrhage Vitreous hemorrhage
Vitreous hemorrhage
zaidhayder3
 
Dots spots lines and rings in ophthalmology
Dots spots lines and rings in ophthalmologyDots spots lines and rings in ophthalmology
Dots spots lines and rings in ophthalmology
Pravin Bhat
 
Normal tension glaucoma
Normal tension glaucomaNormal tension glaucoma
Normal tension glaucoma
Laxmi Eye Institute
 
Epiretinal membrane
Epiretinal membraneEpiretinal membrane
Epiretinal membrane
Pushkal Katara
 
Retinal artery macroaneurysm, Primary retinal Telangiectasia
Retinal artery macroaneurysm, Primary retinal TelangiectasiaRetinal artery macroaneurysm, Primary retinal Telangiectasia
Retinal artery macroaneurysm, Primary retinal Telangiectasia
wasim shah
 
Optic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaOptic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaDr Laltanpuia Chhangte
 
Ocular trauma
Ocular traumaOcular trauma
Ocular trauma
anjoichi
 
Vernal keratoconjunctivitis
Vernal keratoconjunctivitis Vernal keratoconjunctivitis
Vernal keratoconjunctivitis
Vijaygopalraju Ch
 
Red eye evaluation
Red eye evaluationRed eye evaluation
Red eye evaluation
Mosese HULKSTAH Tuapati JNR
 
Retinal artery occlusion
Retinal artery occlusionRetinal artery occlusion
Retinal artery occlusion
SAMEEKSHA AGRAWAL
 
Pathology of Retina and Vitreous
Pathology of Retina and VitreousPathology of Retina and Vitreous
Pathology of Retina and Vitreous
University of the Philippines
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
Tina Chandar
 
Iridocorneal endothelial syndrome
Iridocorneal endothelial syndromeIridocorneal endothelial syndrome
Iridocorneal endothelial syndrome
SSSIHMS-PG
 
Optic atrophy ppt
Optic atrophy pptOptic atrophy ppt
Optic atrophy ppt
Yash Oza
 
Inflm. glaucoma
Inflm. glaucomaInflm. glaucoma
Inflm. glaucoma
Dr. A Huq
 
Ocular hypertension
Ocular hypertensionOcular hypertension
Ocular hypertension
abhishek ghelani
 
Disc edema
Disc edemaDisc edema

What's hot (20)

Ischemic optic neuropathies
Ischemic optic neuropathiesIschemic optic neuropathies
Ischemic optic neuropathies
 
Anatomy of vitreous
Anatomy of vitreousAnatomy of vitreous
Anatomy of vitreous
 
Congenital third ( oculomotor )nerve palsy
Congenital third ( oculomotor )nerve palsyCongenital third ( oculomotor )nerve palsy
Congenital third ( oculomotor )nerve palsy
 
Vitreous hemorrhage
Vitreous hemorrhage Vitreous hemorrhage
Vitreous hemorrhage
 
Dots spots lines and rings in ophthalmology
Dots spots lines and rings in ophthalmologyDots spots lines and rings in ophthalmology
Dots spots lines and rings in ophthalmology
 
Normal tension glaucoma
Normal tension glaucomaNormal tension glaucoma
Normal tension glaucoma
 
Epiretinal membrane
Epiretinal membraneEpiretinal membrane
Epiretinal membrane
 
Retinal artery macroaneurysm, Primary retinal Telangiectasia
Retinal artery macroaneurysm, Primary retinal TelangiectasiaRetinal artery macroaneurysm, Primary retinal Telangiectasia
Retinal artery macroaneurysm, Primary retinal Telangiectasia
 
Optic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaOptic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucoma
 
Ocular trauma
Ocular traumaOcular trauma
Ocular trauma
 
Vernal keratoconjunctivitis
Vernal keratoconjunctivitis Vernal keratoconjunctivitis
Vernal keratoconjunctivitis
 
Red eye evaluation
Red eye evaluationRed eye evaluation
Red eye evaluation
 
Retinal artery occlusion
Retinal artery occlusionRetinal artery occlusion
Retinal artery occlusion
 
Pathology of Retina and Vitreous
Pathology of Retina and VitreousPathology of Retina and Vitreous
Pathology of Retina and Vitreous
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Iridocorneal endothelial syndrome
Iridocorneal endothelial syndromeIridocorneal endothelial syndrome
Iridocorneal endothelial syndrome
 
Optic atrophy ppt
Optic atrophy pptOptic atrophy ppt
Optic atrophy ppt
 
Inflm. glaucoma
Inflm. glaucomaInflm. glaucoma
Inflm. glaucoma
 
Ocular hypertension
Ocular hypertensionOcular hypertension
Ocular hypertension
 
Disc edema
Disc edemaDisc edema
Disc edema
 

Similar to Primary open angle glaucoma

Glaucoma (opthalmology)
Glaucoma (opthalmology)Glaucoma (opthalmology)
Glaucoma (opthalmology)
Ma Wady
 
Retina for undergraduate students
Retina for undergraduate studentsRetina for undergraduate students
Retina for undergraduate students
faculty of medicine -benha university
 
Introduction to Glaucoma by Dr. Iddi.pptx
Introduction to Glaucoma by Dr. Iddi.pptxIntroduction to Glaucoma by Dr. Iddi.pptx
Introduction to Glaucoma by Dr. Iddi.pptx
Iddi Ndyabawe
 
Structural and oct changes in diabetic retinopathy1
Structural and oct changes in diabetic retinopathy1Structural and oct changes in diabetic retinopathy1
Structural and oct changes in diabetic retinopathy1
suchismita Rout
 
Glaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptxGlaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptx
yashabandil155
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
nooralsoub1
 
GLAUCOMA.pdf
GLAUCOMA.pdfGLAUCOMA.pdf
GLAUCOMA.pdf
Meghna Verma
 
Poag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmiPoag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmi
ophthalmgmcri
 
POAG AND PACG
POAG AND PACGPOAG AND PACG
POAG AND PACG
Jayendra Jha
 
Glaucoma
 Glaucoma Glaucoma
Glaucoma
Bhawana Paudel
 
2ry OAG, OHT, NTG
2ry OAG, OHT, NTG2ry OAG, OHT, NTG
Retinal artery occlusion
Retinal artery occlusionRetinal artery occlusion
Retinal artery occlusion
sumit singh maharjan
 
Glaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptxGlaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptx
yashabandil155
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathyPaavan Kalra
 
Eye Surgery.pptx
Eye Surgery.pptxEye Surgery.pptx
Eye Surgery.pptx
CassandraLao1
 
Gradual vision loss
Gradual vision lossGradual vision loss
Gradual vision loss
alijafer99
 
Glaucoma POAG
Glaucoma   POAGGlaucoma   POAG
Glaucoma POAG
anupama manoharan
 

Similar to Primary open angle glaucoma (20)

Glaucoma (opthalmology)
Glaucoma (opthalmology)Glaucoma (opthalmology)
Glaucoma (opthalmology)
 
Retina for undergraduate students
Retina for undergraduate studentsRetina for undergraduate students
Retina for undergraduate students
 
Introduction to Glaucoma by Dr. Iddi.pptx
Introduction to Glaucoma by Dr. Iddi.pptxIntroduction to Glaucoma by Dr. Iddi.pptx
Introduction to Glaucoma by Dr. Iddi.pptx
 
Structural and oct changes in diabetic retinopathy1
Structural and oct changes in diabetic retinopathy1Structural and oct changes in diabetic retinopathy1
Structural and oct changes in diabetic retinopathy1
 
Glaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptxGlaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptx
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
GLAUCOMA.pdf
GLAUCOMA.pdfGLAUCOMA.pdf
GLAUCOMA.pdf
 
Poag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmiPoag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmi
 
POAG AND PACG
POAG AND PACGPOAG AND PACG
POAG AND PACG
 
Glaucoma
 Glaucoma Glaucoma
Glaucoma
 
Diabetic Retinopathy
Diabetic RetinopathyDiabetic Retinopathy
Diabetic Retinopathy
 
2ry OAG, OHT, NTG
2ry OAG, OHT, NTG2ry OAG, OHT, NTG
2ry OAG, OHT, NTG
 
Retinal artery occlusion
Retinal artery occlusionRetinal artery occlusion
Retinal artery occlusion
 
Glaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptxGlaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptx
 
aion.pptx
aion.pptxaion.pptx
aion.pptx
 
Glaucoma Screening
Glaucoma ScreeningGlaucoma Screening
Glaucoma Screening
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Eye Surgery.pptx
Eye Surgery.pptxEye Surgery.pptx
Eye Surgery.pptx
 
Gradual vision loss
Gradual vision lossGradual vision loss
Gradual vision loss
 
Glaucoma POAG
Glaucoma   POAGGlaucoma   POAG
Glaucoma POAG
 

More from faculty of medicine -benha university

Rock'n roll with glaucoma
Rock'n roll with glaucomaRock'n roll with glaucoma
Rock'n roll with glaucoma
faculty of medicine -benha university
 
Errors 2
Errors 2Errors 2
Errors 1
Errors 1Errors 1
Cornea 2
Cornea 2Cornea 2
Cornea 1
Cornea 1Cornea 1
Uveitis
UveitisUveitis
Uvea 1 slideshare
Uvea 1 slideshareUvea 1 slideshare
Lid 2 slideshare
Lid 2 slideshareLid 2 slideshare
Lid 1 slideshare
Lid 1 slideshareLid 1 slideshare
Laser in ophthalmology
Laser in ophthalmologyLaser in ophthalmology
Eye & systemic diseases 4th year
Eye & systemic diseases 4th yearEye & systemic diseases 4th year
Eye & systemic diseases 4th year
faculty of medicine -benha university
 
Orbit
OrbitOrbit
Vitreous
VitreousVitreous
Conjunctiva
ConjunctivaConjunctiva
Rvo guidelines
Rvo guidelinesRvo guidelines
Psudo & latent squint
Psudo & latent squintPsudo & latent squint
Squint (Anatomy, phsiology)
Squint (Anatomy, phsiology)Squint (Anatomy, phsiology)
Squint (Anatomy, phsiology)
faculty of medicine -benha university
 
Congenital glaucoma
Congenital glaucomaCongenital glaucoma

More from faculty of medicine -benha university (20)

Rock'n roll with glaucoma
Rock'n roll with glaucomaRock'n roll with glaucoma
Rock'n roll with glaucoma
 
Errors 2
Errors 2Errors 2
Errors 2
 
Errors 1
Errors 1Errors 1
Errors 1
 
Cornea 2
Cornea 2Cornea 2
Cornea 2
 
Cornea 1
Cornea 1Cornea 1
Cornea 1
 
Uveitis
UveitisUveitis
Uveitis
 
Uvea 1 slideshare
Uvea 1 slideshareUvea 1 slideshare
Uvea 1 slideshare
 
Lid 2 slideshare
Lid 2 slideshareLid 2 slideshare
Lid 2 slideshare
 
Lid 1 slideshare
Lid 1 slideshareLid 1 slideshare
Lid 1 slideshare
 
Laser in ophthalmology
Laser in ophthalmologyLaser in ophthalmology
Laser in ophthalmology
 
Eye & systemic diseases 4th year
Eye & systemic diseases 4th yearEye & systemic diseases 4th year
Eye & systemic diseases 4th year
 
Orbit
OrbitOrbit
Orbit
 
Vitreous
VitreousVitreous
Vitreous
 
Conjunctiva
ConjunctivaConjunctiva
Conjunctiva
 
Ocula er
Ocula er Ocula er
Ocula er
 
Rvo guidelines
Rvo guidelinesRvo guidelines
Rvo guidelines
 
Psudo & latent squint
Psudo & latent squintPsudo & latent squint
Psudo & latent squint
 
Squint (Anatomy, phsiology)
Squint (Anatomy, phsiology)Squint (Anatomy, phsiology)
Squint (Anatomy, phsiology)
 
Congenital glaucoma
Congenital glaucomaCongenital glaucoma
Congenital glaucoma
 
2ry angle closure glaucoma
2ry angle closure glaucoma2ry angle closure glaucoma
2ry angle closure glaucoma
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 

Recently uploaded (20)

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 

Primary open angle glaucoma

  • 1. At least 2 out of 3 If only 1 finding
  • 2.
  • 3. • Disturbance of the structural or functional integrity of the optic nerve, in which; IOP > 21 mmHg Glaucomatous ONH damage Characteristic visual field changes Open AC angle Absent signs of 2ry glaucoma or a non glaucomatous cause of optic neuropathy
  • 4. • The higher the IOP, the greater the likelihood of glaucoma • More common in old age • More common in Black individuals • Siblings, offspring • More common in Myopic individuals • Hypertension, Diabetes, Migraine
  • 5. • Direct mechanical damage to RNF • Ischaemic damage
  • 6. • Nothing • Except in late cases when the patient complains of restricted visual field • Steroids (elevates IOP), ℬ blockers e.g. for hypertension (lowers IOP) • Trauma, surgery, inflammation • Cardiovascular, respiratory disease; for proper tailoring of medications
  • 7. • Phasing (Note time of the day), Asymmetry • C/D ratio (Asymmetry), Peri papillary area, RNFL defect • Not affected except in advanced cases • Not affected except in advanced cases (RAPD in post glaucomatous OA) • Open angle • To exclude causes of 2ry glaucoma
  • 8. • Measure IOP while the patient is fasting • Drink 1 litre over 5 - 15 minutes • Measure IOP subsequently every 15 minutes for one hour • A rise in IOP of 6 to 8 mmHg or an increase from baseline of 30% or more at any time during the hour was considered a positive test.
  • 9. • To adjust the IOP reading according to the central corneal thickness. • Pseudo-colour map of ONH & peri-papillary RNFL thickness. • The visual field defect corresponds to the pattern of fibres in the retinal area served
  • 10. ‫مهم‬‫جدا‬ • can form at a relatively early stage, often superonasally from the earliest to the latest
  • 11. •the defect is bounded by the horizontal midline, corresponding to the retinal nerve fibre layer horizontal raphe.
  • 12. •Less common than nasal step, WHY?!!
  • 13. •Develop from coalescent para-central scotomas •Baring of the blind spot = extension from the blind spot around fixation
  • 14.
  • 15. • Develops when superior and inferior arcuate defects become continuous
  • 16. • A small island of central vision
  • 17. • 1ry vs 2ry glaucoma • Causes of visual field defects mimic glaucoma field defects e.g. ONH drusen, tilted ONH • Prevent functional impairment of vision within the patient’s lifetime by slowing the rate of ganglion cell loss closer to that of the normal population.
  • 18. • Increases uveoscleral outflow • Increases trabecular outflow • Latanoprost • Once daily at bed time • Conjunctival hyperaemia • Eye lash thickening, lengthening & hyper pigmentation • Irreversible iris hyper pigmentation • Peri ocular skin hyper pigmentation • Cystoid macular edema • Promotion of herpetic keratitis • Anterior uveitis • Travaprost • Bimatoprost
  • 19. • Decreases aqueous production by ciliary epithelium • Timolol • Twice daily (not at bed time to avoid profound hypotension) • Ocular: Allergy, PEE • Systemic: 1. Bronchospasm; contraindicated in asthmatic patients 2. Bradycardia, Hypotension, Heart block, Heart failure 3. Dyslipidemia, headache, decrease lipido • Betaxolol (increases ON blood flow) • Levobunolol
  • 20. • Decreases aqueous production by ciliary epithelium • Increases uveoscleral outflow • Brimonidine • Twice daily • Ocular: Allergic conjunctivitis • Systemic: 1. Xerostomia 2. Cross the blood brain barrier (CI under the age of 2 years) • Apraclonidine
  • 21. • Decreases aqueous production by ciliary epithelium • Dorzolamide • Twice daily • Ocular: Allergic blepharo-conjunctivitis • Systemic: 1. Idiosyncrasy (Bone marrow suppression) • Brinzolamide
  • 22. •improve convenience and patient compliance •more cost effective • Timolol + Dorzolamide (Cosopt) • Timolol + Travaprost (Duotrav) • Timolol + Brimonidine (Combigan)
  • 23. • Decreases aqueous production by ciliary epithelium • Acetazolmide • Used for control of acute attack of glaucoma with high IOP • Ocular: Choroidal effusion • Systemic: 1. Paraesthesia 2. Renal stones 3. GIT disturbances 4. Malaise
  • 24. •Create an osmotic gradient so that water is ‘drawn out’ from the vitreous into the blood • Mannitol (IV) • Used for control of acute attack of glaucoma with high IOP • Systemic: 1. Cardiovascular overload 2. Urine retention 3. Headache • Glycerol (Oral) • Isosorbide (Oral)
  • 25. • Beta blockers • CAI • Alpha 2 agonists • PG derivatives • Alpha 2 agonists
  • 26. • Start with single line (usually PG derivative or Beta blocker) • Choose the drug with fewest side effects, lowest concentration • Usually after 2-4 weeks • Response to the drug is assessed against the desired target IOP • Target IOP is tailored according to the patient: Age Presenting IOP ONH changes Field defects
  • 27. • Subsequent assessment is set for further 3-6 months • ONH exam is done in each visit • Perimetry is done every 6-12 months • Gonioscopy is done every 12 months as AC angle tend to narrow with age • Patient compliance • Proper target IOP setting • Diurnal variation
  • 28. • Substitute to another drug, then review • Add another drug or use fixed combination Laser trabeculoplasty (LTP) involves the delivery of laser to the trabecular meshwork with the aim of enhancing aqueous outflow and thereby lowering IOP.
  • 29. ALT SLT LASER Argon Nd YAG Mechanism of action Thermal damage to TM, leading to mechanical opening of TM spaces Selectively target melanin pigment in trabecular meshwork (TM) cells, leaving non-pigmented structures unscathed. Repeatability Not repeatable Could be repeated Electron Microscopy of TM
  • 30. • Poorly controlled POAG with medical or laser therapy • Poor compliance with medical treatment • Advanced POAG requiring very low target IOP • To create a fistula between the AC & the sub-conjunctival space from which the aqueous drains.
  • 31.
  • 32. • Blebitis, Endophthalmitis • Treatment; IV Fortified antibiotics (Vancomycin + Ceftazidime), Vitrectomy
  • 33. • With Deep AC >> Filed bleb (Sub-conjunctival fibrosis) • With Shallow AC >> Pupillary Block >> Malignant Glaucoma (Aqueous misdirection)
  • 34. • With Deep AC >> Choroidal detachment • With Shallow AC >> Over Filtration >> Bleb Leak
  • 35.
  • 36. •In non-penetrating filtration surgery the AC is not entered and the internal trabecular meshwork is preserved, thus reducing the incidence of postoperative over filtration with hypotony & its potential sequelae. •Two concentric lamellar scleral flaps are fashioned & the deep flap excised leaving behind a thin membrane consisting of trabeculum/Descemet membrane through which aqueous diffuses from the AC to the subconjunctival space.